147 related articles for article (PubMed ID: 37938089)
21. Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study.
Chen F; Lu X; Shu X; Peng Q; Tian X; Wang G
Intern Med J; 2015 Jun; 45(6):641-7. PubMed ID: 25827843
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020.
Sun KY; Fan Y; Wang YX; Zhong YJ; Wang GF
Semin Arthritis Rheum; 2021 Feb; 51(1):175-191. PubMed ID: 33383294
[TBL] [Abstract][Full Text] [Related]
23. Enhanced formation and impaired degradation of neutrophil extracellular traps in dermatomyositis and polymyositis: a potential contributor to interstitial lung disease complications.
Zhang S; Shu X; Tian X; Chen F; Lu X; Wang G
Clin Exp Immunol; 2014 Jul; 177(1):134-41. PubMed ID: 24611519
[TBL] [Abstract][Full Text] [Related]
24. Myositis-specific autoantibodies in dermatomyositis/polymyositis with interstitial lung disease.
Li L; Wang H; Wang Q; Wu C; Liu C; Zhang Y; Cheng L; Zeng X; Zhang F; Li Y
J Neurol Sci; 2019 Feb; 397():123-128. PubMed ID: 30616054
[TBL] [Abstract][Full Text] [Related]
25. [Measurement and clinical significance of serum monocyte chemoattractant protein-1 in patients with polymyosits/dermatomyosits].
Chen F; Shu XM; Wang DX; Wang GC; Lu X
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):204-8. PubMed ID: 22516988
[TBL] [Abstract][Full Text] [Related]
26. [Outcome in patients with interstitial lung disease and polymyositis-dermatomyositis--a subgroup with poor prognosis].
Takizawa H; Suzuki N; Yanagawa T; Okazaki H; Satoh M; Akiyama N; Kohyama T; Kawasaki S; Ito K; Oka T
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Oct; 34(10):1093-7. PubMed ID: 8953902
[TBL] [Abstract][Full Text] [Related]
27. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
Gono T; Kaneko H; Kawaguchi Y; Hanaoka M; Kataoka S; Kuwana M; Takagi K; Ichida H; Katsumata Y; Ota Y; Kawasumi H; Yamanaka H
Rheumatology (Oxford); 2014 Dec; 53(12):2196-203. PubMed ID: 24970922
[TBL] [Abstract][Full Text] [Related]
28. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study.
Ye S; Chen XX; Lu XY; Wu MF; Deng Y; Huang WQ; Guo Q; Yang CD; Gu YY; Bao CD; Chen SL
Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and prognostic implications of peripheral blood lymphocyte subsets in patients with anti-MDA5 antibody positive dermatomyositis-interstitial lung disease.
Ren FP; Chen Q; Yao SS; Feng L; Xue XY; Zhao WC; Wang D; Zhao ZL; Gu SW; Li T; Shen YW; Gao L; Zang XL; Bao XY; Tong ZH
BMC Pulm Med; 2023 Oct; 23(1):411. PubMed ID: 37898737
[TBL] [Abstract][Full Text] [Related]
30. Survival and outcomes after lung transplantation for connective tissue disease-associated interstitial lung diseases.
Yang X; Wei D; Liu M; Wu B; Zhang J; Xu H; Ye S; Liu F; Hu C; Chen J
Clin Rheumatol; 2021 Sep; 40(9):3789-3795. PubMed ID: 33755837
[TBL] [Abstract][Full Text] [Related]
31. Interstitial lung disease in polymyositis and dermatomyositis.
Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
[TBL] [Abstract][Full Text] [Related]
32. AST/ALT ratio as a predictor of mortality and exacerbations of PM/DM-ILD in 1 year-a retrospective cohort study with 522 cases.
Li R; Zhu WJ; Wang F; Tang X; Luo F
Arthritis Res Ther; 2020 Sep; 22(1):202. PubMed ID: 32950060
[TBL] [Abstract][Full Text] [Related]
33. Interstitial lung disease in polymyositis and dermatomyositis.
Chen IJ; Jan Wu YJ; Lin CW; Fan KW; Luo SF; Ho HH; Liou LB; Tsai WP; Chen JY; Yang CH; Kuo CF; Yu KH
Clin Rheumatol; 2009 Jun; 28(6):639-46. PubMed ID: 19247576
[TBL] [Abstract][Full Text] [Related]
34. A bibliometric analysis of the research status and trends in studies on polymyositis and dermatomyositis with interstitial lung disease from 2000 to 2022 using Web of Science.
Ma XN; Feng W; Chen SL; Zhong XQ; Zheng XX; Lin CS; Xu Q
Immun Inflamm Dis; 2024 Feb; 12(2):e1190. PubMed ID: 38376948
[TBL] [Abstract][Full Text] [Related]
35. Interstitial lung disease in polymyositis and dermatomyositis.
Hirakata M; Nagai S
Curr Opin Rheumatol; 2000 Nov; 12(6):501-8. PubMed ID: 11092199
[TBL] [Abstract][Full Text] [Related]
36. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment.
Schnabel A; Reuter M; Biederer J; Richter C; Gross WL
Semin Arthritis Rheum; 2003 Apr; 32(5):273-84. PubMed ID: 12701038
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics of dermatomyosits/polymyositis associated interstitial lung disease according to the autoantibody.
Kishaba T; McGill R; Nei Y; Ibuki S; Momose M; Nishiyama K; Nagano H; Yamashiro S
J Med Invest; 2018; 65(3.4):251-257. PubMed ID: 30282869
[TBL] [Abstract][Full Text] [Related]
38. Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis.
Chen F; Wang D; Shu X; Nakashima R; Wang G
Rheumatol Int; 2012 Dec; 32(12):3909-15. PubMed ID: 22198664
[TBL] [Abstract][Full Text] [Related]
39. HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung Disease.
Shu X; Peng Q; Lu X; Wang G
PLoS One; 2016; 11(8):e0161436. PubMed ID: 27537498
[TBL] [Abstract][Full Text] [Related]
40. The prevalence and effects of treatments of rapidly progressive interstitial lung disease of dermatomyositis/polymyositis adults: A systematic review and meta-analysis.
Wang H; Lv J; He J; Wu W; Zhong Y; Cao S; Cai Y; Wang Q
Autoimmun Rev; 2023 Aug; 22(8):103335. PubMed ID: 37164215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
